-
Nov 19, 2020, 14:59 PM
by
The Verisense platform provides complete, high quality, reproducible clinical trial data, while placing minimum burden on sponsors, CROs, site staff and participants.
Full story
-
Nov 19, 2020, 14:59 PM
by
Scilligence informatics platform users now have the ability to access CAS’s high-quality scientific content directly in our web-based informatics solutions, including Scilligence Inventory and Scilligence ELN.
Full story
-
Nov 19, 2020, 14:59 PM
by
CMO growth hampered by innovator approvals from mega cap pharma, yet contract clinical and recombinant vector manufacturing growing in demand
Full story
-
Nov 19, 2020, 14:59 PM
by
Ardigen and The BioCollective today announced a research collaboration aimed at the development of the world’s first microbiome-based biomarker candidates for Parkinson’s Disease.
Full story
-
Nov 19, 2020, 14:59 PM
by
Full story
-
Nov 19, 2020, 14:57 PM
by
A pilot trial at The Medication Adherence Expertise Center of the University Medical Center Groningen in the Netherlands is determining whether Pill Connect’s smart bottle system can support patients with tuberculosis (TB) with their medication adherence.
Full story
-
Nov 19, 2020, 14:56 PM
by
Page & Page and Partners, the global creative communications agency specialising in health, wellness and lifestyle, is today announcing the appointment of three new staff members joining the team on a full time basis.
The new joiners are:
• Asma Shirazi - Account Director
• Emily Sidlow - Senior Account Manager
• Isabelle Nicholson-Rose - Account Executive
They will all be joining the Client Services team, headed by Rachel Harris and will be working on clients including Novartis, Abbott Diagnostics, Fresenius Kabi, L&R, Align Technology and IQVIA.
Full story
-
Nov 19, 2020, 14:53 PM
by
Potential for a New Standard of Care to Improve Diagnostic Accuracy for Breast Cancer Exclusively from H&E Biopsy/Resection Images
Full story
-
Nov 19, 2020, 14:52 PM
by
Full story
-
Nov 19, 2020, 14:51 PM
by
Full story
-
Nov 19, 2020, 01:00 AM
by
User Not Found
Bio-IT World | COVID-19 is switching the risk paradigm for biotech and pharma. It’s too risky, now, not to do something digital. It’s driving changes in investing as well. A recent panel discussion explored how venture capital and new tech companies evaluate technology, invest cash, and plan to move forward.
Full story
-
Nov 17, 2020, 01:00 AM
by
User Not Found
Bio-IT World | A decades-old technology initially used to hide secret messages in dots of DNA—along with Oxford Nanopore sequencing—could get a reboot as a tracking system for commodities that might be too small or numerous for tagging with QR codes or radio-frequency identification, such as experimental drugs and controlled substances.
Full story
-
Nov 13, 2020, 14:26 PM
by
User Not Found
Bio-IT World | Illumina has announced the commercial availability of the P3 high-output flow cell, offering 1.1 billion reads in a single sequencing run. The company also announced the commercial availability of the NextSeq 1000.
Full story
-
Nov 13, 2020, 01:00 AM
by
User Not Found
Bio-IT World | A look at how COVID-19 patients fare after recovery, Mount Sinai’s new ML model analyzes EHRs, overlapping genes in viruses, conferred immunity from other coronaviruses, and a picture of RNA-RNA interactions. Plus a new Intel system at LLNL for COVID-19 research, Baylor’s coronavirus curriculum, and a recommended vaccine distribution framework.
Full story
-
Nov 12, 2020, 01:00 AM
by
User Not Found
Bio-IT World | The Department of Veterans Affairs (VA) and the Department of Energy (DOE) have teamed up to develop disease risk prediction models using deep learning, according to Ravi Madduri, a computer scientist at the DOE’s Argonne National Laboratory and co-lead of the collaboration.
Full story
-
Nov 11, 2020, 14:51 PM
by
User Not Found
Bio-IT World | New products, collaborations and deployments from the past two months from Quantum, Mission Bio, Seqster, Takeda, Optibrium, the Pistoia Alliance, Caris Life Sciences, Genomenon, and more.
Full story
-
Nov 10, 2020, 01:00 AM
by
User Not Found
Bio-IT World | Pharma has had a long history with data. Of course, it wasn’t always digital but there’s always been a data trail. We asked Bryn Roberts from Roche for insights gleaned from his nearly three decades in the pharma industry, mainly in roles related to data science, information technology, and automation. Generating and collecting data has never really been a problem, he said. Managing it, however, has always been a challenge.
Full story
-
Nov 6, 2020, 10:38 AM
by
User Not Found
Bio-IT World I Isolated cannabis compounds decrease cytokines, spike protein disrupts blood-brain barrier, aprotinin potential treatment, D614F mutation made virus more contagious, seven forms of disease identified, and new nanoparticle vaccine a promising candidate. Plus: Cornea of the eye may be resistant, propranolol reduces inflammation, autoimmune antibody culprit for blood clots, and lung damage found in ‘long COVID’.
Full story
-
Nov 5, 2020, 14:58 PM
by
User Not Found
Bio-IT World | Data governance is a somewhat fluid term, encompassing all aspects of making sure our data are accurate, consistent, current, and secure. Successful data governance relies on input from scientists, IT teams, and executives, and it must remain flexible as stakeholders change, business interests evolve, and collaborations mature.
Full story
-
Nov 4, 2020, 12:56 PM
by
User Not Found
Bio-IT World | Gaming and science—two seemingly incompatible areas of activity—have come together nicely in the case of citizen science games such as Foldit, Phylo, and Borderlands Science, as reported by academics close to the action who presented at the recent Bio-IT World Conference & Expo Virtual. The games are all played online, involve analyzing large sets of data, and endeavoring to solve real scientific problems. And players get credit individually (when willing) or as a crowd when findings appear in scholarly, peer-reviewed publications.
Full story